Aurora Cannabis

Canadian cannabis company

ACB Toronto Stock Exchange · home listing ACB NYSE ISIN CA05156X1087 SEC CIK 1683541
Follow Aurora Cannabis Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 CAD · IFRS
Net income −CAD 17.2M
EPS, diluted -
Operating income −CAD 24M
Net income by quarter
CAD 3.8M
−CAD 13.2M
CAD 28.2M
−CAD 17.2M
Q1 25 Q2 25 Q3 25 Q4 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−CAD 4B−CAD 3B−CAD 2B−CAD 1BCAD 0CAD 1BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25CAD 343.3MCAD 1.6M
FY24CAD 269.6M−CAD 69.3M
FY23CAD 221.3M−CAD 1.7B
FY22CAD 245.3M−CAD 692M
FY21CAD 268.7M−CAD 3.3B
FY20CAD 245.5M−CAD 293.5M
FY19CAD 55.2MCAD 71.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2554.6%1.4%0.5%
FY2448.9%−16.7%−25.7%
FY239.6%−104.6%−776%
FY22−8.8%−115.3%−282.2%
FY21−7.4%−173.3%−1221.7%
FY2058%−129.6%−119.5%
FY1978.8%−173.5%130.3%
Free cash flowOperating cash flow minus capital expenditure
−CAD 800M−CAD 600M−CAD 400M−CAD 200MCAD 0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23−CAD 142.5M
FY22−CAD 263.7M
FY21-
FY20−CAD 606.5M
FY19−CAD 218.6M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Aurora Cannabis
  • Healthcare median
−1500%−1000%−500%0%500%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearAurora CannabisHealthcare median
FY250.5%−30.6%
FY24−25.7%−47%
FY23−776%−58%
FY22−282.2%−80.4%
FY21−1221.7%−71.9%
FY20−119.5%−62.2%
FY19130.3%−46.3%